Contract HHSN261201800081P
Irepertoire Inc · Department Of Health And Human Services · December 12, 2017
Irepertoire Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on December 12, 2017 for $7,000 of work in biological product (except diagnostic) manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 23, 2023.
Contract details
- PIID
- HHSN261201800081P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical- Laboratory Testing
- Place of performance
- Bethesda, MD
- First action
- December 12, 2017
- Latest action
- February 23, 2023
Description
RNA SEQUENCING 012467
Modification timeline
-
February 23, 2023Mod P00001$-70
-
December 12, 2017Base awardIGF::CL,CT::IGF RNA SEQUENCING 012467$6.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN261201800081P?
Contract HHSN261201800081P is a federal contract awarded to Irepertoire Inc by Department Of Health And Human Services on December 12, 2017 for $7,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN261201800081P?
Irepertoire Inc won contract HHSN261201800081P from Department Of Health And Human Services.
How much is contract HHSN261201800081P worth?
Contract HHSN261201800081P has obligated $7,000 to date.